Critical Innovations was pleased to present three oral presentations and one poster session at the Military Health System Research Symposium in Orlando, Florida last month. The MHSRS provides a venue for presenting new scientific knowledge resulting from military-unique research and development and is the Department of Defense’s foremost scientific meeting.
Dr. Ross Donaldson, President & CEO of Critical Innovations, delivered the following oral presentations:
"BurRapid™ Intracranial Access Platform for Traumatic Brain Injury” under the breakout session: Traumatic Brain Injury Treatment for Early Combat, In-theater Administration
“A novel, reverse-phase-shifting, thermoreversible foam with deployment system for the treatment of penetrating globe trauma in a newly described large-animal model” under the breakout session: Expeditionary Diagnostics and Treatment of Vision Injury
“A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model – a pilot study” under the breakout session: Advanced Battlefield Care of Severe Burn Casualties at the Point of Need: Prehospital to Definitive Care
The company also presented the following poster presentation:
“Donaldson Decompression Needle™ (DDN™) for the Rapid Treatment of Tension Pneumothorax” under the poster session: Advances in Prolonged Care
Critical Innovations values the opportunity to
present research on its developing technologies in this collaborative setting focused on the unique medical needs of the Warfighter.